Why Hologic’s Breast Cancer Index data matter for precision oncology beyond recurrence risk
Hologic’s Breast Cancer Index is changing endocrine therapy decisions. The bigger test is adoption in real-world breast cancer care.
Did OM1 just prove AI-powered real-world evidence can survive FDA scrutiny?
FDA-grade evidence is getting bigger and harder to collect. OM1’s Hologic study shows how AI may change medtech submissions.
Can Hologic’s breast imaging AI close one of mammography’s most stubborn detection gaps?
Hologic’s latest breast imaging AI data suggests stronger detection of hard-to-find cancers. Read what it could mean for screening adoption.